About Stream Biomedical

 Founded in 2016, Stream Biomedical is a clinical-stage biotechnology company developing LG3, a first-in-class biologic designed to protect and restore the brain by activating its natural repair systems.

The company’s lead program is focused on Alzheimer’s disease and related dementias (ADRD), with additional potential applications in stroke, traumatic brain injury, and other neurological conditions.

Derived from a natural repair protein, LG3 is designed to engage multiple pathways involved in neurovascular integrity, inflammation, and recovery.

Stream Biomedical is advancing LG3 through disciplined clinical development, guided by rigorous science and a commitment to improving outcomes for patients affected by devastating neurological diseases.